271 related articles for article (PubMed ID: 30291111)
21. Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma.
Han JJ; O'byrne M; Stenson MJ; Maurer MJ; Wellik LE; Feldman AL; McPhail ED; Witzig TE; Gupta M
Blood Cancer J; 2018 Nov; 8(11):110. PubMed ID: 30420593
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Hsi ED; Horwitz SM; Carson KR; Pinter-Brown LC; Rosen ST; Pro B; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Collie AM; Gruver AM; Grzywacz BJ; Turakhia S; Shustov AR; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Park SI; Foss FM
Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):193-200. PubMed ID: 28209473
[TBL] [Abstract][Full Text] [Related]
23. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma.
Hayashi E; Takata K; Sato Y; Tashiro Y; Tachiyama Y; Sawada-Kitamura S; Hiramatsu Y; Sugiguchi S; Nose S; Hirokawa M; Ando M; Abd Alkader L; Maeda Y; Tanimoto M; Yoshino T
Hum Pathol; 2013 Sep; 44(9):1927-36. PubMed ID: 23706909
[TBL] [Abstract][Full Text] [Related]
24. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
[TBL] [Abstract][Full Text] [Related]
25. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
Agostinelli C; Piccaluga PP; Went P; Rossi M; Gazzola A; Righi S; Sista T; Campidelli C; Zinzani PL; Falini B; Pileri SA
J Clin Pathol; 2008 Nov; 61(11):1160-7. PubMed ID: 18755717
[TBL] [Abstract][Full Text] [Related]
26. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified.
Lin Y; Chen WM; Wang C; Chen XY
Cancer Biomark; 2017; 18(4):339-347. PubMed ID: 28128734
[TBL] [Abstract][Full Text] [Related]
28. Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma.
Arakawa F; Miyoshi H; Yoshida N; Nakashima K; Watatani Y; Furuta T; Yamada K; Moritsubo M; Takeuchi M; Yanagida E; Shimasaki Y; Kohno K; Kataoka K; Ohshima K
Cancer Med; 2021 Oct; 10(19):6786-6794. PubMed ID: 34477310
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological analysis of immunohistochemical expression of retinoic acid-related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified.
Yanagida E; Miyoshi H; Kawamoto K; Nakashima K; Matsuda K; Yamada K; Muto R; Nagafuji K; Seto M; Ohshima K
Hum Pathol; 2018 Sep; 79():86-92. PubMed ID: 29775622
[TBL] [Abstract][Full Text] [Related]
30. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
[TBL] [Abstract][Full Text] [Related]
31. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
Niitsu N
J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
[TBL] [Abstract][Full Text] [Related]
32. The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL).
Julamanee J; Kayasut K; Lekhakula A
J Med Assoc Thai; 2015 Oct; 98(10):950-6. PubMed ID: 26638586
[TBL] [Abstract][Full Text] [Related]
33. High intratumoural galectin-1 expression predicts adverse outcome in ALK
Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
[TBL] [Abstract][Full Text] [Related]
34. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
[TBL] [Abstract][Full Text] [Related]
35. Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.
Wai CMM; Chen S; Phyu T; Fan S; Leong SM; Zheng W; Low LCY; Choo SN; Lee CK; Chung TH; Ban KHK; Ghosh S; Lie S; Kato S; Nakamura S; Takahashi E; Ko YH; Khoury JD; Chuang SS; Au-Yeung RKH; Tan SY; Lim ST; Ong CK; Ho YH; Poon LM; De Mel S; Jeyasekharan AD; Chng WJ; Otto F; Quintanilla-Martinez L; Zanardi F; Iannelli F; Tripodo C; Pitt JJ; Ng SB
Haematologica; 2022 Aug; 107(8):1864-1879. PubMed ID: 35021606
[TBL] [Abstract][Full Text] [Related]
36. Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.
Debackere K; Marcelis L; Demeyer S; Vanden Bempt M; Mentens N; Gielen O; Jacobs K; Broux M; Verhoef G; Michaux L; Graux C; Wlodarska I; Gaulard P; de Leval L; Tousseyn T; Cools J; Dierickx D
Nat Commun; 2021 Jun; 12(1):3705. PubMed ID: 34140493
[TBL] [Abstract][Full Text] [Related]
37.
Maura F; Dodero A; Carniti C; Bolli N; Magni M; Monti V; Cabras A; Leongamornlert D; Abascal F; Diamond B; Rodriguez-Martin B; Zamora J; Butler A; Martincorena I; Tubio JMC; Campbell PJ; Chiappella A; Pruneri G; Corradini P
Haematologica; 2021 Nov; 106(11):2918-2926. PubMed ID: 33054126
[TBL] [Abstract][Full Text] [Related]
38. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
[TBL] [Abstract][Full Text] [Related]
39. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified.
Zhang W; Wang L; Zhou D; Cui Q; Zhao D; Wu Y
Leuk Lymphoma; 2011 Jan; 52(1):46-52. PubMed ID: 21077742
[TBL] [Abstract][Full Text] [Related]
40. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus.
Hartmann S; Gesk S; Scholtysik R; Kreuz M; Bug S; Vater I; Döring C; Cogliatti S; Parrens M; Merlio JP; Kwiecinska A; Porwit A; Piccaluga PP; Pileri S; Hoefler G; Küppers R; Siebert R; Hansmann ML
Br J Haematol; 2010 Feb; 148(3):402-12. PubMed ID: 19863542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
